So, the FXR gene is supposed to have some characteristics of a tumor suppressor in colon cancer; in this context, the restoration of basal FXR expression might slow or prevent the progression of colon cancer allowing it to be a potential prognostic and target for the treatment of CRC. The gene discussed is NR1H4; the disease is malignant colon neoplasm.